Please provide your email address to receive an email when new articles are posted on . Nearly 80% of patients with cirrhosis awaiting liver transplant reported clinically significant pain. Pain, ...
Around 13% of patients with a dementia diagnosis may instead have advanced liver disease — also called cirrhosis — which can cause reversible cognitive decline, researchers at the Virginia ...
Please provide your email address to receive an email when new articles are posted on . The pharmacokinetics of survodutide were not affected by cirrhosis. The dual agonist was “generally tolerable” ...
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...
A comprehensive review assessed the ways that proper nutrition could help reduce the adverse effects of hepatic encephalopathy in patients with hepatic encephalopathy. A recent review published in the ...
The addition of SGLT2 inhibitors was associated with a nearly one third lower incidence of serious liver events in individuals with cirrhosis who were receiving diuretic therapy, a large cohort study ...
Patients in the Phase 3 MAESTRO-NAFLD-1 trial achieved a statistically significant mean reduction of 6.7 kPa in liver stiffness, the largest reported in compensated MASH cirrhosis populations. 51% of ...
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback